Sigachi Industries Ltd. witnessed a 5% jump in its share price following a major breakthrough announcement for its group company, Trimax Biosciences Pvt. Ltd.
The company secured a communication from the European Directorate for the Quality of Medicines & Health Care (EDQM) regarding its latest Certificate of Suitability (CEP) filing for Propafenone Hydrochloride, a critical active pharmaceutical ingredient (API).
This certification is a strategic milestone, granting Trimax Biosciences the regulatory approval to export Propafenone Hydrochloride to Europe and other CEP-compliant markets. The development positions the company for growth in the pharmaceutical sector, enhancing its global footprint.
Stock Details Today:
- Open Price: ₹51.00
- Day’s High: ₹53.90
- Day’s Low: ₹50.57
- 52-Week High: ₹95.90
- 52-Week Low: ₹43.35
As of 9:59 am, Sigachi Industries shares were trading 5.12% higher at Rs 53.75 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
